BB Healthcare Trust PLC Block Listing Application (5259R)
29 Octubre 2019 - 10:31AM
UK Regulatory
TIDMBBH
RNS Number : 5259R
BB Healthcare Trust PLC
29 October 2019
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR
INDIRECTLY, TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC
OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN
THE UNITED KINGDOM) OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE
UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM
OR TO PROFESSIONAL INVESTORS IN IRELAND)
29 October 2019
BB Healthcare Trust plc
Block Listing Application
The Board of BB Healthcare Trust plc (the "Company") announces
that application has been made to the Financial Conduct Authority
and to the London Stock Exchange for a block listing of 83,997,614
ordinary shares of one penny each ("Ordinary Shares") in the
Company to be admitted to the Official List and to trading on the
London Stock Exchange's market for listed securities
("Admission").
The above 83,997,614 Ordinary Shares to be block listed may be
issued pursuant to the Company's existing authorities to issue new
Ordinary Shares on a non pre-emptive basis. These Ordinary Shares
may be issued inter alia to satisfy market demand and for the
purposes of managing the premium to net asset value (cum income)
per Ordinary Share at which the Ordinary Shares are trading. When
issued, these Ordinary Shares will rank pari passu with the
existing Ordinary Shares in issue. It is expected that Admission
will become effective on 5 November 2019.
The Company's LEI is: 213800HQ3J3H9YF2UI82
Enquiries:
Peel Hunt LLP
Liz Yong (Corporate Broking)
Mark Thompson (Sales)
Telephone: +44 (0) 207 418 8900
J.P. Morgan Cazenove
James Bouverat, Eddie Nissen (Sales)
Telephone: +44 (0) 207 134 2224
Disclaimer
This announcement does not constitute a prospectus relating to
the Company and does not constitute, or form part of, any offer or
invitation to sell or issue, or any solicitation of any offer to
purchase or subscribe for, any shares in the Company in any
jurisdiction nor shall it, or any part of it, or the fact of its
distribution, form the basis of, or be relied on in connection with
or act as any inducement to enter into, any contract therefor.
Peel Hunt LLP ("Peel Hunt") and J.P. Morgan Cazenove, which are
authorised and regulated by the Financial Conduct Authority, are
acting for the Company only in connection with the matters
described in this announcement and are not acting for or advising
any other person, or treating any other person as their client, in
relation thereto and will not be responsible for providing the
regulatory protection afforded to clients of Peel Hunt and J.P.
Morgan Cazenove or advice to any other person in relation to the
matters contained herein.
The shares of the Company have not been and will not be
registered under the US Securities Act of 1933, and may not be
offered or sold in the United States absent registration or an
applicable exemption from the registration requirements. Moreover,
the shares of the Company have not been, nor will they be,
registered under the applicable securities laws of Australia,
Canada, the Republic of South Africa, Japan or any member state of
the EEA (other than the United Kingdom). Further, the Company will
not be registered under the US Investment Company Act of 1940, as
amended. Subject to certain exceptions, the shares of the Company
may not be offered or sold in the United States, Australia, Canada,
the Republic of South Africa, Japan or any member state of the EEA
(other than the United Kingdom or to professional investors in
Ireland) or to, or for the account or benefit of, any national,
resident or citizen of the United States, Australia, Canada, the
Republic of South Africa, Japan or any member state of the EEA
(other than the United Kingdom or to professional investors in
Ireland). The share issuance programme, and the distribution of
this announcement, in other jurisdictions may be restricted by law
and the persons into whose possession this announcement comes
should inform themselves about, and observe, any such
restrictions.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ALSQKLFLKBFLFBD
(END) Dow Jones Newswires
October 29, 2019 12:31 ET (16:31 GMT)
Bellevue Healthcare (LSE:BBH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Bellevue Healthcare (LSE:BBH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024